<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; Voices from the Fight to Stop Tuberculosis</title>
	<atom:link href="http://www.newtbdrugs.org/blog/category/tb-voices/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Sat, 19 May 2012 12:57:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Community Engagement through Drama</title>
		<link>http://www.newtbdrugs.org/blog/community-engagement-through-drama/</link>
		<comments>http://www.newtbdrugs.org/blog/community-engagement-through-drama/#comments</comments>
		<pubDate>Tue, 17 Apr 2012 17:16:46 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB R&D Spotlight Interviews]]></category>
		<category><![CDATA[TB Stigma]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[WGND Podcast Series]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[community engagement]]></category>
		<category><![CDATA[education]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[podcast]]></category>
		<category><![CDATA[social impact]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[tb/hiv]]></category>
		<category><![CDATA[voices]]></category>
		<category><![CDATA[youth empowerment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3729</guid>
		<description><![CDATA[Dr. Gill Black is the co-founder and Director of Health and Welfare at The Sustainable Livelihoods Foundation (SLF).  In this inteview, we discuss with Dr. Black one of SLF's groundbreaking projects that uses drama to engage local communities around issues related to TB and HIV/AIDS.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/community-engagement-through-drama/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Announcing the InnovateTB Contest</title>
		<link>http://www.newtbdrugs.org/blog/announcing-the-innovatetb-contest/</link>
		<comments>http://www.newtbdrugs.org/blog/announcing-the-innovatetb-contest/#comments</comments>
		<pubDate>Sat, 24 Mar 2012 04:01:13 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[InnovateTB]]></category>
		<category><![CDATA[InTB]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3623</guid>
		<description><![CDATA[Announcing the InnovateTB contest! Innovations are revolutionizing TB. Tell us your story! On World TB Day, the Stop TB Partnership Working Group on New TB Drugs (WGND) announces the InnovateTB Contest to encourage and highlight innovations to achieve zero deaths from TB in this generation. We are inviting interested participants to take two simple steps: [...]]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/announcing-the-innovatetb-contest/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Podcast Interview with Dr. Tawanda Gumbo</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-tawanda-gumbo/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-tawanda-gumbo/#comments</comments>
		<pubDate>Thu, 01 Mar 2012 21:54:15 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[WGND Podcast Series]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[pk/pd studies]]></category>
		<category><![CDATA[podcast]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3529</guid>
		<description><![CDATA[In this week's interview, we discuss with Dr. Tawanda Gumbo his recently published paper that puts forth evidence that nonadherence may not be the prime reason for the emergence of drug resistance in TB, his research interests and background, the recent debate on the role of efflux pumps in drug tolerance and his research to optimize TB drugs.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-tawanda-gumbo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kick TB Campaign:  Scoring Big in South Africa and Beyond</title>
		<link>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/</link>
		<comments>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 19:22:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3403</guid>
		<description><![CDATA[The Kick TB Campaign is a unique project that uses the World's most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB).  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Podcast Interview with Dr. Yossef Av-Gay</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-yossef-av-gay/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-yossef-av-gay/#comments</comments>
		<pubDate>Wed, 14 Dec 2011 20:14:50 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Early Drug Development]]></category>
		<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[WGND Podcast Series]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[podcast]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3378</guid>
		<description><![CDATA[This week we interview Dr. Yossef Av-Gay and discuss his recently published paper, his contribution to TB drug discovery and the focus of his research.  Dr. Av-Gay, a professor in the Division of Infectious Diseases at the University of British Columbia, recently published a paper in PNAS that provides evidence to that points to a specific protein that allows Mtb to bypass the body's defenses.  Additional TB R&#038;D news links are included. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-yossef-av-gay/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Podcast interview with Dr. Gyanu Lamicchane</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-gyanu-lamicchane/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-gyanu-lamicchane/#comments</comments>
		<pubDate>Tue, 08 Nov 2011 21:47:25 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[WGND Podcast Series]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[JHU]]></category>
		<category><![CDATA[nih/niaid]]></category>
		<category><![CDATA[podcast]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3325</guid>
		<description><![CDATA[Microbial geneticist Dr.  Gyanu Lamichhane of the Johns Hopkins Center for Tuberculosis Research is one of 49 recipients of the New Innovator Award, which is given to promising scientists in the early stages of their careers and is supported directly with $1.5 million in research funding over five years.  In this interview, we discuss the award and the related research that lead to the award, as well as, Dr. Lamichhane's motivation to work with TB.  Additional links to TB R&#038;D news are included.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-podcast-interview-with-dr-gyanu-lamicchane/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Winstone&#8217;s Voice</title>
		<link>http://www.newtbdrugs.org/blog/winstones-voice/</link>
		<comments>http://www.newtbdrugs.org/blog/winstones-voice/#comments</comments>
		<pubDate>Wed, 12 Oct 2011 21:24:39 +0000</pubDate>
		<dc:creator>John-Michael</dc:creator>
				<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[tb/hiv]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3253</guid>
		<description><![CDATA[As has been widely reported, we lost Winstone Zulu, a tireless advocate for TB/HIV. Chief among his gifts was the ability to speak with passion about his subject, finding the precise balance between hard facts, personal history, and an inspiring call to action.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/winstones-voice/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update: Podcast Interview with Dr. Sanjib Bhakta</title>
		<link>http://www.newtbdrugs.org/blog/podcast-interview-with-dr-sanjib-bhakta/</link>
		<comments>http://www.newtbdrugs.org/blog/podcast-interview-with-dr-sanjib-bhakta/#comments</comments>
		<pubDate>Wed, 05 Oct 2011 19:21:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[WGND Podcast Series]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[podcast]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3074</guid>
		<description><![CDATA[This week's interview is with Dr. Sanjib Bhkata who is Head of Mycobacteria Research Laboratory, Microbiology, Department of Biological Sciences, Institute of Structural and Molecular Biology at the Birbeck University of London.  Dr. Bhakta's Laboratory has developed an innovative method for screening compounds that is more efficient and just as accurate as more widely used methods.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/podcast-interview-with-dr-sanjib-bhakta/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview with TB Alert&#8217;s Mike Mandelbaum</title>
		<link>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/</link>
		<comments>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/#comments</comments>
		<pubDate>Thu, 21 Jul 2011 16:03:09 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2977</guid>
		<description><![CDATA[Mike Mandelbaum is Chief Executive of TB Alert, which is the UK's National and International Tuberculosis charity - the only British charity working solely on fighting TB in the UK and overseas.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Jenniffer Dietrich, Challenge Facility for Civil Society</title>
		<link>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/</link>
		<comments>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/#comments</comments>
		<pubDate>Fri, 01 Jul 2011 13:22:20 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[voices]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2912</guid>
		<description><![CDATA[Jenniffer Dietrich is Technical Officer at the Challenge Facility for Civil Society of the Stop TB Partnership. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

